Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Statistics

Total Valuation

TPEX:6620 has a market cap or net worth of TWD 17.49 billion. The enterprise value is 14.69 billion.

Market Cap	17.49B
Enterprise Value	14.69B

Important Dates

The next estimated earnings date is Friday, December 26, 2025.

Earnings Date	Dec 26, 2025
Ex-Dividend Date	Jul 2, 2025

Share Statistics

TPEX:6620 has 156.86 million shares outstanding. The number of shares has increased by 4.73% in one year.

Current Share Class	156.86M
Shares Outstanding	156.86M
Shares Change (YoY)	+4.73%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.48%
Owned by Institutions (%)	2.27%
Float	101.10M

Valuation Ratios

The trailing PE ratio is 26.34.

PE Ratio	26.34
Forward PE	n/a
PS Ratio	13.08
PB Ratio	4.14
P/TBV Ratio	5.09
P/FCF Ratio	73.90
P/OCF Ratio	69.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.79, with an EV/FCF ratio of 62.08.

EV / Earnings	23.67
EV / Sales	10.98
EV / EBITDA	18.79
EV / EBIT	19.12
EV / FCF	62.08

Financial Position

The company has a current ratio of 9.17, with a Debt / Equity ratio of 0.01.

Current Ratio	9.17
Quick Ratio	9.13
Debt / Equity	0.01
Debt / EBITDA	0.06
Debt / FCF	0.21
Interest Coverage	930.27

Financial Efficiency

Return on equity (ROE) is 17.42% and return on invested capital (ROIC) is 13.40%.

Return on Equity (ROE)	17.42%
Return on Assets (ROA)	12.36%
Return on Invested Capital (ROIC)	13.40%
Return on Capital Employed (ROCE)	17.95%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.34
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6620 has paid 63.97 million in taxes.

Income Tax	63.97M
Effective Tax Rate	9.34%

Stock Price Statistics

The stock price has increased by +41.68% in the last 52 weeks. The beta is 0.70, so TPEX:6620's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+41.68%
50-Day Moving Average	85.41
200-Day Moving Average	78.68
Relative Strength Index (RSI)	75.68
Average Volume (20 Days)	719,109

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6620 had revenue of TWD 1.34 billion and earned 620.70 million in profits. Earnings per share was 4.23.

Revenue	1.34B
Gross Profit	1.21B
Operating Income	773.05M
Pretax Income	684.67M
Net Income	620.70M
EBITDA	776.63M
EBIT	773.05M
Earnings Per Share (EPS)	4.23

Balance Sheet

The company has 2.85 billion in cash and 50.61 million in debt, giving a net cash position of 2.80 billion or 17.83 per share.

Cash & Cash Equivalents	2.85B
Total Debt	50.61M
Net Cash	2.80B
Net Cash Per Share	17.83
Equity (Book Value)	4.22B
Book Value Per Share	26.93
Working Capital	3.01B

Cash Flow

In the last 12 months, operating cash flow was 252.27 million and capital expenditures -15.61 million, giving a free cash flow of 236.66 million.

Operating Cash Flow	252.27M
Capital Expenditures	-15.61M
Free Cash Flow	236.66M
FCF Per Share	1.51

Margins

Gross margin is 90.66%, with operating and profit margins of 57.80% and 46.41%.

Gross Margin	90.66%
Operating Margin	57.80%
Pretax Margin	51.19%
Profit Margin	46.41%
EBITDA Margin	58.06%
EBIT Margin	57.80%
FCF Margin	17.69%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.36%.

Dividend Per Share	1.50
Dividend Yield	1.36%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-4.73%
Shareholder Yield	-3.29%
Earnings Yield	3.55%
FCF Yield	1.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6620 has an Altman Z-Score of 16.79 and a Piotroski F-Score of 3.

Altman Z-Score	16.79
Piotroski F-Score	3